GNRH1 and central precocious puberty: The use of gonadotropin-releasing hormone analogs (GnRH-a) in the treatment of CPP has been a significant advancement in pediatric endocrinology, offering an active tool to delay onset of puberty in children who experience early sexual maturation [1,2].